| 40.82 -0.88 (-2.11%) | 02-23 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 47.64 | 1-year : | 50.44 |
| Resists | First : | 40.79 | Second : | 43.18 |
| Pivot price | 40.4 |
|||
| Supports | First : | 36.9 | Second : | 30.7 |
| MAs | MA(5) : | 37.77 |
MA(20) : | 40.38 |
| MA(100) : | 38.4  |
MA(250) : | 35.35 |
|
| MACD | MACD : | -0.9 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 3.6 |
D(3) : | 3.4 |
| RSI | RSI(14): 33.8 |
|||
| 52-week | High : | 45.71 | Low : | 28.86 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ AMEH ] has closed above bottom band by 10.9%. Bollinger Bands are 41.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 37.9 - 38.15 | 38.15 - 38.38 |
| Low: | 36.34 - 36.66 | 36.66 - 36.95 |
| Close: | 36.85 - 37.35 | 37.35 - 37.8 |
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
Sun, 25 Feb 2024
At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely? - Simply Wall St
Fri, 23 Feb 2024
Apollo Medical Holdings, Inc. (AMEH) Soars 7.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Thu, 22 Feb 2024
Apollo Medical Holdings, Inc. Becomes Astrana Health, Inc. - PR Newswire
Tue, 20 Feb 2024
Apollo Medical Holdings, Inc. (AMEH) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Thu, 08 Feb 2024
An excellent week for Apollo Medical Holdings, Inc.'s (NASDAQ:AMEH) institutional owners who own 47% as one-year ... - Yahoo Finance
Wed, 07 Feb 2024
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt? - Simply Wall St
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 45 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 25.7 (%) |
| Held by Institutions | 47 (%) |
| Shares Short | 2,750 (K) |
| Shares Short P.Month | 2,730 (K) |
| EPS | 1.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 12.73 |
| Profit Margin | 3.3 % |
| Operating Margin | 11.2 % |
| Return on Assets (ttm) | 6.2 % |
| Return on Equity (ttm) | 9.7 % |
| Qtrly Rev. Growth | 9.8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 29.66 |
| EBITDA (p.s.) | 2.63 |
| Qtrly Earnings Growth | -6 % |
| Operating Cash Flow | 134 (M) |
| Levered Free Cash Flow | 143 (M) |
| PE Ratio | 35.9 |
| PEG Ratio | 3.2 |
| Price to Book value | 2.93 |
| Price to Sales | 1.25 |
| Price to Cash Flow | 12.5 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|